About Us

Your Trusted Partner in Clinical Research

Our Mission Statement

Our mission, under the direction of our Principal Investigator, Dr. Felix Sigal, is to conduct clinical trials with the highest level of scientific rigor and ethical standards to advance the development of safe and effective medical treatments. We strive to provide excellent patient care, to foster collaboration between healthcare providers, and to contribute to the body of medical knowledge through innovative research.

In line with the Office of Minority Health and Health Equity (OMHHE), we aim to promote health equity and eliminate disparity among different populations. To achieve this, we strive to understand the barriers that prevent marginalized communities from participating in clinical trials, actively work to eliminate them and continuously monitor our progress to ensure we are marking meaningful strides towards health equity in clinical research.

Our therapeutic areas of focus are in diabetes-related disorders spanning from Type 2 Diabetes Mellitus, Gastroparesis, Insulin Resistance, Obesity, Cardiovascular Outcomes, Chronic Kidney Disease, Orthostatic Hypotension and Atherosclerotic Diseases.

We pride ourselves in executing a robust recruitment of volunteer participants, timely collection and entry of data, ICH and GCP compliance, delivering high-quality data to our research partners, and raising the standard of care for our patients by advancing treatment options.

We strive to maintain open communication with our Sponsors, patients and the broader medical community to promote transparency and trust. Our goal is to contribute to the development of new treatments and therapies that will ultimately benefit patients worldwide.